'Rescheduling' cannabis would ease restrictions on science, opening the door to the largest investment in cannabis research we've seen to date
By Raymond Palidora Edited by Nicoletta Lanese, Hannah Osborne, Kimberly Hickok Published 24 July 2026 In Opinion MEMBER EXCLUSIVE When you purchase through links on our site, we may earn an affiliate commission. Clinicians participating in state medical cannabis programs generally "certify" and "recommend" specific cannabis products to certain patients, rather than write traditional prescriptions. Additionally, a handful of cannabis-derived and cannabinoid-based medications have received formal Food and Drug Administration (FDA) approval.
- ▪By Raymond Palidora Edited by Nicoletta Lanese, Hannah Osborne, Kimberly Hickok Published 24 July 2026 In Opinion MEMBER EXCLUSIVE When you purchase through links on our site, we may earn an affiliate commission.
- ▪Clinicians participating in state medical cannabis programs generally "certify" and "recommend" specific cannabis products to certain patients, rather than write traditional prescriptions.
- ▪Additionally, a handful of cannabis-derived and cannabinoid-based medications have received formal Food and Drug Administration (FDA) approval.
Live Science files mainly under science. We currently carry 137 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Live Science |
| Canonical URL | https://www.livescience.com/health/medicine-drugs/rescheduling-cannabis-would-ease-restrictions-on-science-opening-the-door-to-the-largest-investment-in-cannabis-research-weve-seen-to-date-opinion |
| Publication time | Fri, 24 Jul 2026 09:00:00 +0000 |
| Retrieval time | 2026-07-24T09:07:33.860Z |
| Last seen | 2026-07-24T09:07:33.860Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | UmObW6U0YIhC |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Health Medicine & Drugs 'Rescheduling' cannabis would ease restrictions on science, opening the door to the largest investment in cannabis research we've seen to date Rescheduling cannabis could mark a major shift in research, but it alone will not eliminate the scientific, regulatory and patient-access challenges that have shaped medical cannabis for decades. By Raymond Palidora Edited by Nicoletta Lanese, Hannah Osborne, Kimberly Hickok Published 24 July 2026 In Opinion MEMBER EXCLUSIVE When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. "Rescheduling" cannabis would mean loosening restrictions on how the drug can be studied by scientists, which could lead to new approved uses for cannabis in medicine.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Live Science.
Discussion
0 commentsMore from Live Science
